Webinar | Lincoln International and Latham & Watkins Discuss Capital Infusion Transactions

On May 14, 2020, Chris Gregory, a Managing Director in Lincoln’s Valuations & Opinions Group and head of the Fairness & Solvency Opinion Practice is joined by Alex Stevenson, Managing Director and Co-Head of Lincoln International’s Special Situations Group, and Steve Stokdyk, former Co-Chair of Latham & Watkins Public Company Representation Practice, to discussed various aspects of capital infusion transactions. Topics discussed include:

  • The broad impact that the Coronavirus pandemic is having on company valuations and their leverage and liquidity
  • Current state of the private capital markets and options that are available to companies to address a funding gap through a third-party capital provider
  • Affiliate party capital infusions as an alternative to a third-party capital raise, whereby the incumbent private equity sponsor injects capital into its existing portfolio companies from the same fund or from a successor fund
  • Legal and corporate governance considerations for capital infusion transactions with a focus on cross-fund transactions
  • Overview of the fairness opinion analytical framework for a capital infusion transaction and valuation considerations for the current environment

 

Click here to download a PDF of this presentation.

Summary

  • Lincoln International hosted a webcast with Latham & Watkins to discuss capital infusion transactions and implications of COVID-19.

  • Lincoln International has created a Playbook to support business leaders in documenting and articulating their COVID-19 response. To request a copy, click here.

Contributors

Meet Professionals with Complementary Expertise

Related Perspectives